Online inquiry

IVTScrip™ mRNA-Human ARFRP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28574MR)

This product GTTS-WK28574MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARFRP1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001134758.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10139
UniProt ID Q13795
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARFRP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28574MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK18400MR IVTScrip™ mRNA-Human ALDH3A2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALDH3A2
GTTS-WK0972MR IVTScrip™ mRNA-Human CD292, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA CD292
GTTS-WK19678MR IVTScrip™ mRNA-Human ANGEL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANGEL2
GTTS-WK14863MR IVTScrip™ mRNA-Human AMY2B, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMY2B
GTTS-WK18122MR IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA Alkaline phosphatase
GTTS-WK27566MR IVTScrip™ mRNA-Human ATL1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATL1
GTTS-WK20263MR IVTScrip™ mRNA-Human AMY2B, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AMY2B
GTTS-WK24899MR IVTScrip™ mRNA-Human ATP5EP2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATP5EP2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW